Actively Recruiting
Direct Transcranial Electrical Stimulation in Tobacco Addiction (tDCS)
Led by Assistance Publique - Hôpitaux de Paris · Updated on 2025-09-12
100
Participants Needed
1
Research Sites
339 weeks
Total Duration
On this page
Sponsors
A
Assistance Publique - Hôpitaux de Paris
Lead Sponsor
U
URC-CIC Paris Descartes Necker Cochin
Collaborating Sponsor
AI-Summary
What this Trial Is About
In summary, there are currently many therapeutic tools for achieving some degree of control or even cessation of tobacco addictive use. No single therapy seems to have proven itself sufficiently effective to be the preferred treatment axis in the management of this addiction. We can also point out that so far the main treatments aimed at reducing or controlling the craving phenomenon are of a pharmacological nature, thus exposing the participants to the side effects inherent to this type of treatment. In this perspective, the establishment of non invasive brain stimulation (TdCS), acting in a targeted manner on craving and whose effects would be mild and transient, appears quite justified, especially in addition to psychotherapy. In the context of the management of addictive pathologies, the choice of smoking dependence seems relevant to us insofar as this addiction represents a major public health problem.
CONDITIONS
Official Title
Direct Transcranial Electrical Stimulation in Tobacco Addiction (tDCS)
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Men and women over the age of 18
- Nicotine dependent subjects according to the Fagerström test (score ≥5)
- Subjects consuming daily tobacco
- Subjects understanding and reading French and able to express themselves in this language
- Signed informed consent to participate indicating understanding of the study and agreement to comply
- Affiliation to the French social security scheme or beneficiary of such a scheme
- No other method to decrease or stop smoking at the same time as the study
You will not qualify if you...
- Guardianship
- Pregnant or lactating woman
- Patient under AME
- Subject being in the exclusion period of another study or provided for by the "National Volunteer File"
- Subjects with intracranial hypertension
- Subject unlikely to cooperate with the study and/or weak cooperation anticipated
- Treatment with buproprion or varenicline in progress
- Episode or family history of epilepsy or convulsion
- Disease causing damage to the brain (aneurysm, tumor, etc.)
- Cochlear or ocular implant
- Stimulator or cardiac defibrillator
- Presence of metal in the skull (clip on aneurysm, prosthesis, etc.)
- Eczema on the scalp
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Psychiatrie Adultes Et Addictologie
Paris, IDF, France, 75006
Actively Recruiting
Research Team
F
Florence THIBAUT, PHD
CONTACT
M
Marie BENHAMMANI-GODARD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here